Patents Assigned to Boost Biopharma, Inc.
  • RECOMBINANT POLYPEPTIDES CONTAINING AT LEAST ONE IMMUNOGENIC FRAGMENT AND ANTIBODY FC REGION AND USES THEREOF
    Publication number: 20250109173
    Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) spike glycoprotein, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: December 30, 2022
    Publication date: April 3, 2025
    Applicant: BOOST BIOPHARMA, INC.
    Inventors: Fritz Schomburg, David Rancour
  • CORONAVIRUS VACCINE COMPOSITIONS AND USES THEREOF
    Publication number: 20250090654
    Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein. Also provided are a method for preventing, inhibiting, reducing, eliminating, protecting, or delaying the onset of an infection or an infectious clinical condition caused by a coronavirus in a subject which includes administering to the subject the recombinant polypeptide, and a method for inducing an immune response against a coronavirus in a subject, which includes administering to the subject the recombinant polypeptide.
    Type: Application
    Filed: December 30, 2022
    Publication date: March 20, 2025
    Applicant: BOOST BIOPHARMA, INC.
    Inventors: Fritz Schomburg, David Rancour
  • RECOMBINANT POLYPEPTIDES CONTAINING AT LEAST ONE IMMUNOGENIC FRAGMENT AND USES THEREOF
    Publication number: 20220288194
    Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: April 25, 2022
    Publication date: September 15, 2022
    Applicant: Boost Biopharma, Inc.
    Inventors: Fritz M. Schomburg, David M. Rancour
  • Recombinant polypeptides containing at least one immunogenic fragment and antibody fc region and uses thereof
    Patent number: 11358990
    Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein, and pharmaceutical compositions containing the same.
    Type: Grant
    Filed: November 24, 2021
    Date of Patent: June 14, 2022
    Assignee: Boost Biopharma, Inc.
    Inventors: Fritz M. Schomburg, David M. Rancour
  • RECOMBINANT POLYPEPTIDES CONTAINING AT LEAST ONE IMMUNOGENIC FRAGMENT AND ANTIBODY FC REGION AND USES THEREOF
    Publication number: 20220073569
    Abstract: Provided is a recombinant polypeptide containing at least one immunogenic fragment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike glycoprotein, and pharmaceutical compositions containing the same.
    Type: Application
    Filed: November 24, 2021
    Publication date: March 10, 2022
    Applicant: Boost Biopharma, Inc.
    Inventors: Fritz M. Schomburg, David M. Rancour